Cargando…
Role of lenalidomide in the treatment of peripheral T-cell non-Hodgkin lymphomas
T-cell lymphomas (TCLs) represent a group of lymphoid neoplasms characterized by an aggressive clinical course, even after an anthracycline-containing regimen. Novel agents for patients with relapsed/refractory TCL are urgently needed. Lenalidomide is an oral drug with immunomodulatory, antiangiogen...
Autores principales: | Cencini, Emanuele, Fabbri, Alberto, Mecacci, Bianca, Bocchia, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546656/ https://www.ncbi.nlm.nih.gov/pubmed/34733611 http://dx.doi.org/10.5306/wjco.v12.i10.882 |
Ejemplares similares
-
Lenalidomide and Temozolomide Combination in a Very Elderly Patient with CNS Relapse of Diffuse Large B-Cell Lymphoma
por: Cencini, Emanuele, et al.
Publicado: (2017) -
Primary CNS lymphoma: latest updates and a 10-year monocenter experience
por: Cencini, Emanuele, et al.
Publicado: (2018) -
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment
por: Diamantidis, Michael D, et al.
Publicado: (2021) -
The Role of Tumor-Associated Macrophages in Hematologic Malignancies
por: Cencini, Emanuele, et al.
Publicado: (2021) -
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients
por: Gozzetti, Alessandro, et al.
Publicado: (2020)